Details
- Status
- Closed
- Opening date
- Deadline
- Department
- Directorate-General for Health and Food Safety
Target audience
Public health community
Why we are consulting
Public consultation on strengthening EU cooperation on Health Technology Assessment (HTA)
Policy fields
Public health, Internal Market, Industry, Entrepreneurship and SMEs, Research and Innovation
Target group(s)
All citizens and organisations were welcome to contribute to this consultation. Contributions were particularly sought from patient organisations, public authorities and government-appointed bodies responsible for commissioning or executing HTA reports, national health insurance and social security institutions and associations representing such bodies, companies developing pharmaceuticals, medical devices and other technologies as well as associations representing these industries, healthcare providers and professional associations, as well as academic institutions.
Period of consultation
From 21/10/2016 to 20/01/2017
Objective of the consultation
This public consultation aimed to gather detailed views and opinions relating to the future of the EU cooperation on HTA, as proposed in the Inception Impact Assessment published by the European Commission (see Reference documents). The results of this public consultation will feed into the impact assessment process which the Commission services are currently preparing on strengthening EU cooperation on HTA.
The strategy for the public consultation is outlined in this document.
Results of the online public consultation
See the report of the online public consultation.
In the following you can find a link to the responses that were received in the public consultation.
The responses are listed by groups of respondents.
- Citizens: Results
- Administrations, associations and other organisations:
- Input received outside the online public consultation: Results
Definitions
Health Technology is a term used to cover certain aspects of healthcare products or services, such as:
- Pharmaceuticals (any medicinal products, from simple pain killers and gastro-protectors to anti-cancer medicines)
- Medical devices/equipment (for example X-ray machines, pacemakers, insulin pumps)
- Medical and surgical procedures (for example laparoscopy, hip replacement surgery)
- Other measures for disease prevention, diagnosis or treatment used in healthcare (such as vaccination programmes, pregnancy tests, screening test for early diagnostic of cancers, etc.).
Health technology assessment (HTA) measures the added value of a new health technology in comparison to existing technologies/current standard of care. HTA is defined as a multidisciplinary process that summarises information in a systematic, unbiased and robust manner about the medical, economic, organisational, social and ethical issues related to the use of a health technology. The goal of HTA is to support decision makers at national, regional or local level in their efforts to ensure that patients are treated with the best available treatment while keeping the health budgets under control/in balance. HTA also encourages economic stakeholders to focus their research on areas where they expect significant innovation.
Contact details
Responsible service: Directorate-General for Health and Food Safety - Unit B4 Medical products: safety, quality, innovation
E-mail: SANTE-HTA
ec [dot] europa [dot] eu (SANTE-HTA[at]ec[dot]europa[dot]eu)
Any queries about the public consultation should be sent to this mailbox.
Protection of personal data
The policy on "protection of individuals with regard to the processing of personal data by the Community institutions" is based on Regulation (EC) N° 45/2001 of the European Parliament and of the Council of 18 December 2000. More information is available here
Specific privacy statement
Contributions will be published on the Internet. It is important to read the specific privacy statement attached to this consultation for information on how your personal data and contribution will be dealt with.